Laboratorio de Bioquímica-Genética, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico.
PLoS One. 2013 Jul 22;8(7):e69031. doi: 10.1371/journal.pone.0069031. Print 2013.
We have previously proposed triosephosphate isomerase of Giardia lamblia (GlTIM) as a target for rational drug design against giardiasis, one of the most common parasitic infections in humans. Since the enzyme exists in the parasite and the host, selective inhibition is a major challenge because essential regions that could be considered molecular targets are highly conserved. Previous biochemical evidence showed that chemical modification of the non-conserved non-catalytic cysteine 222 (C222) inactivates specifically GlTIM. The inactivation correlates with the physicochemical properties of the modifying agent: addition of a non-polar, small chemical group at C222 reduces the enzyme activity by one half, whereas negatively charged, large chemical groups cause full inactivation.
In this work we used mutagenesis to extend our understanding of the functional and structural effects triggered by modification of C222. To this end, six GlTIM C222 mutants with side chains having diverse physicochemical characteristics were characterized. We found that the polarity, charge and volume of the side chain in the mutant amino acid differentially alter the activity, the affinity, the stability and the structure of the enzyme. The data show that mutagenesis of C222 mimics the effects of chemical modification. The crystallographic structure of C222D GlTIM shows the disruptive effects of introducing a negative charge at position 222: the mutation perturbs loop 7, a region of the enzyme whose interactions with the catalytic loop 6 are essential for TIM stability, ligand binding and catalysis. The amino acid sequence of TIM in phylogenetic diverse groups indicates that C222 and its surrounding residues are poorly conserved, supporting the proposal that this region is a good target for specific drug design.
The results demonstrate that it is possible to inhibit species-specifically a ubiquitous, structurally highly conserved enzyme by modification of a non-conserved, non-catalytic residue through long-range perturbation of essential regions.
我们之前提出了蓝氏贾第鞭毛虫磷酸丙糖异构酶(GlTIM)作为针对贾第虫病(一种最常见的人体寄生虫感染)的合理药物设计的靶标。由于该酶存在于寄生虫和宿主中,选择性抑制是一个主要挑战,因为可以被认为是分子靶标的必需区域高度保守。以前的生化证据表明,对非保守的非催化半胱氨酸 222(C222)的化学修饰可特异性失活 GlTIM。失活与修饰剂的物理化学性质相关:在 C222 处添加非极性的小化学基团会使酶活性降低一半,而带负电荷的大化学基团则会导致完全失活。
在这项工作中,我们使用突变来扩展我们对 C222 修饰引发的功能和结构影响的理解。为此,我们对具有不同物理化学特性的侧链的 GlTIM C222 六个突变体进行了表征。我们发现,突变氨基酸的侧链的极性、电荷和体积会不同程度地改变酶的活性、亲和力、稳定性和结构。数据表明,C222 的突变模拟了化学修饰的影响。C222D GlTIM 的晶体结构显示了在位置 222 引入负电荷的破坏性影响:该突变会扰乱环 7,该酶的一个区域,其与催化环 6 的相互作用对于 TIM 的稳定性、配体结合和催化至关重要。在系统发育上多样化的 TIM 氨基酸序列表明,C222 及其周围的残基保守性较差,这支持了该区域是特异性药物设计的良好靶标的观点。
结果表明,通过对非保守的非催化残基进行长程修饰,可以特异性抑制普遍存在的、结构高度保守的酶。